Developing FGFR4 inhibitors as potential anti-cancer agents via in silico design, supported by in vitro and cell-based testing

by Ho, H.K., Németh, G., Ng, Y.R., Pang, E., Szántai-Kis, C., Zsákai, L., Breza, N., Greff, Z., Horváth, Z., Pató, J., Szabadkai, I., Szokol, B., Baska, F., Orfi, L., Ullrich, A., Kéri, G., Chua, B.T.
Published 2014